Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004782198 | SCV005395855 | pathogenic | Usher syndrome | 2024-09-16 | criteria provided, single submitter | clinical testing | Variant summary: MYO7A c.5710dupC (p.His1904ProfsX7) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant was absent in 247928 control chromosomes (gnomAD). To our knowledge, no occurrence of c.5710dupC in individuals affected with Usher Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as pathogenic. |